Policy, Talent Pool, And Supply Chain Challenges In Biopharmaceuticals
Source: Cytiva

How is the state of the industry being affected by government policies, talent pools, and supply chain constraints? Hear from Dave Tudor, Managing Director of Pharma, HealthTech, and Quality at CPI, a division of the UK's High Value Manufacturing Catapult, to gain valuable insight into this matter. Learn about the UK biopharmaceutical industry’s biggest strengths and greatest challenges, how the UK government can take action to help the industry thrive, what must be done to safeguard the future of the industry, and more.
access the Q&A!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.
Subscribe to Advancing RNA
X
Subscribe to Advancing RNA
Cytiva
This website uses cookies to ensure you get the best experience on our website. Learn more